No Data
No Data
Earnings Preview: WGS to Report Financial Results Pre-market on April 30
Is GeneDx Holdings (NASDAQ:WGS) A Risky Investment?
GeneDx Holdings Corp. (WGS) Rose on Robust Customer Demand
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Announces Target Price $114
Craig-Hallum Sticks to Their Buy Rating for GeneDx Holdings (WGS)
GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million